We are delighted to announce that Prellis Biologics, Inc. has made the short-list for Start-up of the Year in the 2018 3D Printing Industry Awards. Results are announced in May, and decided by public vote.  

CEO Melanie Matheu, PhD brings her multi-disciplinary experience in specialized laser microscopy, cell biology, physiology, and biophysics to address the unsolved biomedical challenge of rapid 3D printing of large, vascularized tissues to Slush 2017 in Helsinki, Finland.


Prellis Biologics in 2018

Here are Prellis we are looking forward to an incredible 2018 while we gear up for some major scientific announcements in Q1 and move towards animal testing with our first products towards the end of the year. Our unique and unparalleled combination of speed, resolution, and non-toxic printing process will allow for significant leaps in the human tissue engineering field. 

Press Release, 09/13/17: Human Tissue Engineering Startup Prellis Biologics Receives Funding to Create Human Organs With 3D Printing